Novozymes ROI - Return on Investment 2011-2023 | NVZMY

Novozymes return on investment for the quarter ending December 31, 2023 was 16.29.

  • Novozymes average return on investment for 2022 was 20.39, a 21.64% decline from 2021.
  • Novozymes average return on investment for 2021 was 26.02, a 21.03% decline from 2020.
  • Novozymes average return on investment for 2020 was 32.95, a 65.24% decline from 2019.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.

Novozymes ROI - Return on Investment 2011-2023 | NVZMY

  • Novozymes average return on investment for 2022 was 20.39, a 21.64% decline from 2021.
  • Novozymes average return on investment for 2021 was 26.02, a 21.03% decline from 2020.
  • Novozymes average return on investment for 2020 was 32.95, a 65.24% decline from 2019.

Roi - return on investment can be defined as an indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity.
Related Stocks
Company NameMarket
Cap
Linde (LIN)$221.6B
Sherwin-Williams (SHW)$96.7B
Ecolab (ECL)$69.7B
PPG Industries (PPG)$29.2B
International Flavors & Fragrances (IFF)$23.3B
Celanese (CE)$9.8B
Axalta Coating Systems (AXTA)$8.7B
CSW Industrials (CSWI)$7B
Element Solutions (ESI)$7B
Arcadium Lithium (ALTM)$5.8B
Balchem (BCPC)$5.7B
Valvoline (VVV)$5.6B
NewMarket (NEU)$5.4B
Nissan Chemical (NNCHY)$4.4B
H B Fuller (FUL)$4.3B
Ashland (ASH)$3.9B
Sensient Technologies (SXT)$3.4B
Quaker Houghton (KWR)$3B
Minerals Technologies (MTX)$2.6B
Hawkins (HWKN)$2.5B
Perimeter Solutions, SA (PRM)$2B
Orbia Advance, S.A.B De C.V (MXCHY)$1.8B
Ingevity (NGVT)$1.7B
DAQO New Energy (DQ)$1.5B
ELEMENTIS (ELMTY)$1.3B
Orion S.A (OEC)$959M
Huabao Holdings (HUIHY)$943M
AdvanSix (ASIX)$832M
Westlake Chemical Partners LP (WLKP)$793M
Green Plains (GPRE)$758M